Testing tumor growth speed in head and neck cancer
Part of Cancer clinical trials.
This study looks at how fast a tumor is growing (tumor growth velocity) and how that relates to outcomes in head and neck squamous cell cancer treated with radiation, with or without chemotherapy. It may help doctors better predict prognosis and tailor treatment plans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have head and neck squamous cell carcinoma in the mouth, throat (oropharynx), larynx, or hypopharynx (T1–T4 stages).
- Your cancer team has decided your treatment will be radiation or radiation plus chemotherapy at the same time.
- Your cancer has not spread to distant parts of the body (no metastases).
- Your treatment plan does not rely on surgery as the main first treatment.
- You can safely receive iodine contrast for CT scans (no history of severe iodine reaction and your kidneys are healthy enough).
- The tumor can be seen clearly on a CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving a slightly different schedule of radiation (more frequent, smaller doses) can improve treatment for people with large head and neck cancers. It is for patients who are getting radiation as their main treatment, sometimes with chemotherapy as well.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
This study uses tumor tissue taken from people with head and neck cancer, then grows it in a lab to better understand the cancer and predict responses. If you have a new or returning cancer and can share key medical details and follow-up information, you may be able to take part.
This trial tests a safer radiation plan that may reduce dose to the opposite (other) side of the neck while still treating the cancer spread risk. It uses special mapping to guide treatment and looks at patients whose cancer is already in an involved lymph node on one side.
This study collects tissue from people with newly diagnosed head and neck squamous cell cancer and grows “mini tumor models” in the lab. The goal is to see how these models respond to new therapies, which may help guide more effective treatment choices in the future.
Hear when a new Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.